Free tool
Diagnostics stocks
We cover 8 companies grouped under the Diagnostics theme. The median market value in the group is $18.40B. Across the group, the median move over the past trading day is +0.42%. Price change over the past year runs from −17.9% to +125.0% across the middle 80 percent of the group, with a median of +18.5%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
8 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| NTRA | Natera, Inc. | $336.71 | +30.49% | +47.14% | +107.24% |
| LH | Labcorp Holdings Inc. | $337.68 | +12.12% | +34.52% | +23.25% |
| DGX | Quest Diagnostics Incorporated | $244.51 | +5.46% | +41.95% | +38.70% |
| GH | Guardant Health, Inc. | $164.92 | +13.37% | +62.10% | +166.52% |
| ERF.PA | Eurofins Scientific SE | 73.26 EUR | +6.92% | +19.56% | +13.76% |
| ESF0.DE | Eurofins Scientific SE | 72.70 EUR | +6.29% | +17.51% | +11.02% |
| TEM | Tempus AI, Inc. | $68.73 | +60.17% | +10.21% | −9.45% |
| BIM.PA | bioMérieux S.A. | 74.35 EUR | −0.80% | −32.10% | −37.52% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.